Community leadership has been minimized, and where it exists, it is under constant pressure to make a profit.
Many questions remain following the FDA’s approval of caplacizumab, specifically, which patients should receive it. The high cost of the drug is...
Smartphone apps can add twists to diagnoses.
Law & Medicine
Question: Employee, a poorly controlled diabetic, accidentally stepped on a nail at work. Surrounding cellulitis and abscess...
It’s up to physicians to build an ethical wall between interests in clinical research.
A peer should never answer and then be expected to wait while your employee tracks you down.
False alarms are terrifying, and false reassurance is cruel, yet all the while, excessive waiting can feel excruciating.
From the Editor
How many clinically shaky fellows do we graduate into our profession every year? How many of us are aware of colleagues who are unskilled, but are...
Many people with metastatic cancer say they wouldn’t want invasive treatment near the end of life. But how do we know when it’s the end?
Once a patient hears “cancer,” they often stop listening. We could go on, spelling out the next steps and treatment options. But patients usually...